Hypertrophic gastropathy -that is, Menetrier's disease -was found, in a retrospective analysis, to be associated with Helicobacter pylori in more than 90% of patients. It is proposed that hypertrophic gastropathy represents a special form of H pylon gastritis in these patients.
Abstract
Hypertrophic gastropathy -that is, Menetrier's disease -was found, in a retrospective analysis, to be associated with Helicobacter pylori in more than 90% of patients. It is proposed that hypertrophic gastropathy represents a special form of H pylon gastritis in these patients. A case is described of a 28 year old woman with Menetrier's disease associated with proved protein loss from the stomach. Treatment with cimetidine for more than three years had little benefit when colonisation by H pylon was detected. Density ofH pylori colonisation and activity of gastritis, which was also present in the first biopsy specimens taken five years ago, were more pronounced in the body than in the antrum, which is in agreement with the characteristics of H pylori gastritis found in other cases with Menetrier's disease. A 14 day antibacterial treatment course with 750 mg amoxicillin three times a day combined with 40 mg omeprazole three times a day was started in April 1991. This resulted in eradication of H pylori and the return to normal of giant folds and the mucosal histology. Serum protein concentrations returned to normal within six weeks and remained normal at two endoscopies during a two year foliow up. This case report suggests that a subgroup of the patients with Menetrier's disease may be healed by the eradication of H pylon. (Gut 1994; 35: 701-704) Hypertrophic gastropathy (Menetrier's disease) is described as a condition of unknown origin, which is characterised by endoscopy by tortuous enlarged gastric folds predominantly localised at the greater curvature or within the entire body region of the stomach. Histologically, it is characterised by considerable elongation and tortuosity of the pits, and cystic dilatations of the body mucosa. The inflammatory cell content is increased, especially in the pit region.'
Protein loss from the stomach is found in more than three quarters of patients, and oedema may be the first clinical sign. Other clinical features are non-specific. ' 3 4 g/l, 1B globulin 4 5 g/l, and y globulin 3 3 gil, and IgG and IgA immunoglobulins were also reduced at 2 40 g/l and 0 5 g/l, respectively (normal range >8 0 and >0 9 g/l, respectively). Protein concentration in a specimen of 24 hour urine was mildly increased at 480 mg.
After "Cr-labelled albumin was given intravenously, 13 Figure) .
A gastroscopy done in April 1986 showed enlarged gastric folds of the body mucosa. Biopsy specimens taken from the antrum and body for histological examination showed moderate unspecific gastritis and considerable foveolar hyperplasia only in the body. On this basis the diagnosis of Menetrier's disease was established.
Treatment with cimetidine 1 g/day was started, which resulted in an increase in serum protein concentrations to the lower limits of normal for albumin and y globulins for a period of two months ( Figure) . In August 1987 the patient became pregnant and cimetidine treatment was stopped. During pregnancy she suffered a further drop in serum protein concentrations, with the lowest total serum protein of 35 g/l and a serum albumin of 25 g/l measured at the time of birth. The clinical course was at its worst during pregnancy with continuous oedema. At term, she gave birth to a healthy girl with normal protein electrophoresis.
Cimetidine was again given after delivery, and again led to a short term increase in serum protein concentrations (Figure) . Cimetidine was continued until April 1991, with little success (Figure) .
When it came to our notice that H pylon gastritis was being discussed as a possible cause of Menetrier's disease,, two biopsy specimens were cultured for H pylori. Four biopsy speci-
ENDOSCOPY AND BIOPSY
At each endoscopic examination two antral biopsy specimens were taken for H pylori culture and six additional specimens, three from the antrum and three from the body, for histological examination. A total of six specimens, including some from the body of the stomach, achieves 98% reliability for detection of H pylori gastritis and for confirming eradication of H pylon.' At each endoscopic examination serum samples were taken and frozen at -25°C for later measurement of H pylori antibodies and gastrin concentrations.
MICROBIOLOGY
Two biopsy specimens were retained for microbiological investigation and were transported in Port-A-Cul medium (Becton & Dickinson, Heidelberg, Germany) at room temperature within four hours to the Department of Microbiology. These specimens were processed immediately upon arrival and streaked on sheep blood agar (blood agar base 2, Oxoid) with Skirrow supplement and non-selective media for aerobic and anaerobic bacteria. Plates were incubated for five to seven days at 37°C in an atmosphere produced by the commercial gas generating kit Anaerocult C (Merck, Darmstadt, Germany (Figure) . The effect of cimetidine on the immunoglobulin concentration was similar, which remained low during the entire initial treatment period (Figure) .
In 1900, at the annual endoscopic examination, we detected H pylorn colonisation in the antrum and body; the Table shows the gastritis classification. Retrospective evaluation of the histological specimens from earlier examinations, including those which had been the basis of the diagnosis of Menetrier's disease, also showed H pylon colonisation in our patient.
At this time we used a H pylori eradicating regimen, a combination of high dose omeprazole and amoxicillin,8 for the first time. This new treatment regimen proved successful in our patient, as was shown when eradication of H pylori was checked four weeks after the treatment finished.
The first sign of clinical improvement was an increase in the serum concentration of total protein and albumin, which was accompanied by an increase in serum immunoglobulins (Figure) .
H pylon was eradicated, which prevailed for at least one year. This was accompanied by a concomittant decrease in the activity and grade of gastritis (Table) .
There was a considerable decline of the H pylon-IgG antibodies. Serum gastrin concentrations were within the normal range but declined after eradication treatment (Table) . The immunological investigation showed no proliferative response of PBMC to H pylori antigens in this patient before and after treatment.
Discussion
Protein losing hypertrophic gastropathy is considered to be a life threatening disease, which may lead to death in some cases either as a direct result of hypoproteinaemia' 2 or as a result of the development of subsequent cancer triggered by chronic hypoglobulinaemia or development of atrophic gastritis.'0 This report shows that, at least in some of the patients, the disease may be healed by eradication ofH pylori.
Recently, a study investigating 138 patients with hypertrophic gastropathy showed that this condition is associated with H pylori in about 90% of patients.3 It is proposed that hypertrophic gastropathy represents a special form of H pylori gastritis in these patients.
In this patient with protein losing hypertrophic gastropathy we identified a more pronounced H pylori colonisation in the body, and a higher activity of gastritis in the body than in the antrum, which is in agreement with the characteristics of H pylori gastritis found in most of the 138 patients in the study of The immunological characterisation of the patient's peripheral response towards H pylori antigens was similar to other H pylori infected patients without Menetrier's disease, which is in accordance with data from other investigators. 18 19 A further complication of protein losing hypertrophic gastropathy is hypogammaglobulinaemia, which increases the risk of fatal infections and the risk of subsequent cancer. Previous studies have found a high correlation between hypertrophic gastropathy and gastric cancer.22 Based on our recent knowledge of H pylori we would prefer to attribute this possibly increased frequency of subsequent cancer to its association with chronic H pylon gastritis.2' Furthermore it is proposed that hypogammaglobulinaemia is possibly a risk factor for an increased frequency of cancer. 10 The data presented suggest that H pylori gastritis is a pathogenic factor in at least a subgroup of patients with hypertrophic gastropathy. Treatment should therefore be considered using a regimen that eradicates H pylori. Furthermore, such treatment could help in the differential diagnosis of other diseases associated with hypertrophic gastric folds, such as diffuse gastric carcinoma or lymphoma. 
